The short answer
Ertugliflozin does not automatically create a need for sodium supplements or a different sodium schedule. Fluid and salt decisions should reflect your blood pressure, kidney and heart status.
What this answer covers
Dietary sodium, salt tablets and oral rehydration products are distinct uses; no universal replacement dose is established.
- Supplement or preparation
- Sodium
- Medication ingredient
- ertugliflozin
What the exact-drug study showed
In a small heart-failure and diabetes study, ertugliflozin increased urine sodium and volume at one week, but these effects diminished by twelve weeks. Some fractional-excretion measures did not change. The study did not test sodium replacement.
Urine loss does not establish a supplement need
A change in sodium handling can occur while fluid status moves toward a healthier level. It does not prove that everyone is sodium deficient. Extra salt could conflict with an existing heart, kidney or blood-pressure plan.
Use an individual fluid and salt plan
Ask the clinician how to manage intake during illness, heat or diarrhea, especially if you also take a diuretic. Do not automatically add salt tablets or override prescribed fluid or sodium limits.
Keep the prescribed medicine plan
Keep the prescribed ertugliflozin plan and tell the clinician about reduced intake, illness, vomiting or diarrhea. Do not change diabetes doses or fluid and salt advice to compensate for a supplement without review.
Know when illness needs urgent review
Ertugliflozin can contribute to volume depletion. Persistent vomiting, inability to drink, marked dizziness or fainting needs assessment. Stop ertugliflozin and seek urgent care for possible ketoacidosis symptoms such as nausea, vomiting, abdominal pain, marked tiredness or difficulty breathing, even if glucose is not very high.
Evidence and practical considerations
Timing & monitoring
The current automatic requirement/timing claim is unsupported. Exact-drug study found early increased urine sodium/volume with attenuation, null fractional-excretion endpoints, and lower extracellular volume; this is not a demonstrated dietary deficiency or replacement benefit.
- Exact scope
- Dietary sodium, salt tablets and oral rehydration products are distinct uses; no universal replacement dose is established. with Exact ertugliflozin L-pyroglutamic acid single-ingredient oral tablets. Exact RxNorm IN1992672; STEGLATRO uses ertugliflozin L-pyroglutamic acid equivalent to the active ingredient. Metformin and sitagliptin combinations excluded.
- Medication form and route
- oral
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- Thirty-four-person heart-failure/type2 diabetes study; no sodium supplementation arm and no universal dietary target or timing result.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed ertugliflozin.
Glucosuria, volume depletion, ketoacidosis precautions; hypoglycemia risk increases with insulin or insulin secretagogues. No routine sodium replacement instruction.
How this applies: Exact RxNorm IN1992672; STEGLATRO uses ertugliflozin L-pyroglutamic acid equivalent to the active ingredient. Metformin and sitagliptin combinations excluded.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 2: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Thirty-four participants with type 2 diabetes and heart failure in randomized placebo-controlled study.
Urine sodium and volume increased at one week with attenuation by twelve weeks; fractional lithium and sodium excretion endpoints did not increase.
How this applies: Only the named drug, preparation, route and measured endpoints apply.
Selected heart failure population and no sodium supplementation or dietary-replacement trial. Physiological excretion change does not establish deficiency.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: e995fb2096d6d62a
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.